As the COVID-19 pandemic continues to evolve, we have more tools than ever to protect the health of Ohioans, especially our most vulnerable. Ohio has built a strong infrastructure of providers for oral antiviral pills and monoclonal antibodies that includes hospitals, federally qualified health centers, retail pharmacies, and long-term care pharmacies across the state.

The Ohio Department of Health (ODH) asks you to help increase awareness of these life-saving treatments and help patients understand how they can access these treatments quickly if eligible. Click here to read a letter from ODH Director Bruce Vanderhoff, MD, MBA, with more information, including key messages to use with patients who might benefit from COVID-19 therapeutics.

It also includes links to resources, such as a recorded webinar developed by the Ohio Hospital Association about COVID-19 treatments featuring infectious disease specialists covering indications for use, high-risk criteria, renal function considerations, dispensing considerations, side effects, warnings and precautions, contraindications, and drug interactions.

If you have additional questions about these resources, please email therapeutics@odh.ohio.gov.